These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6290091)

  • 1. Determination of SA-446 in human whole blood and urine by electron capture-gas liquid chromatography.
    Iwatani T; Naitoh M; Takashina H; Nagamori S; Itoh Y; Iwao J
    Chem Pharm Bull (Tokyo); 1982 Jun; 30(6):2087-93. PubMed ID: 6290091
    [No Abstract]   [Full Text] [Related]  

  • 2. [Inhibition of angiotensin converting enzyme by (2R,4R)-2-(2-hydroxyphenyl)-3-(3-mercaptopropionyl)-4- thiazolidinecarboxylic acid, SA 446].
    Horiuchi M; Terashima T; Fujimura K; Shimokawa K; Iso T
    Yakugaku Zasshi; 1984 Dec; 104(12):1257-62. PubMed ID: 6099853
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antinephritic effect of SA-446, an angiotensin I converting enzyme inhibitor, on crescentic-type anti-GBM nephritis in rats].
    Suzuki Y; Ito M; Yamada H; Saitho N; Tsukushi Y
    Nihon Jinzo Gakkai Shi; 1985 Nov; 27(11):1485-93. PubMed ID: 3007819
    [No Abstract]   [Full Text] [Related]  

  • 4. [High-performance liquid chromatography of organosulfur compounds using the postcolumn ligand exchange reaction with iodoplatinate. Application to the simultaneous determination of (2R,4R)-2-(o-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidine carboxylic acid (SA446), an angiotensin converting enzyme inhibitor and its urinary metabolites].
    Horiuchi M; Takashina H; Fujimura K; Iso T
    Yakugaku Zasshi; 1986 Nov; 106(11):1028-33. PubMed ID: 3031265
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of angiotensin I-converting enzyme inhibitor (SA-446) on renal function in dogs.
    Takada T; Yamamoto K; Fujioka S; Tamaki T; Fukui K; Abe Y
    Jpn J Pharmacol; 1985 Jun; 38(2):227-30. PubMed ID: 2993720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of 3 different angiotensin converting enzyme inhibitors, MK 421, SQ 14225 and SA 446 on renal function and blood pressure in patients with essential hypertension].
    Tajima J; Abe K; Yasujima M; Tanno M; Yoshinaga K
    Nihon Jinzo Gakkai Shi; 1984 Jun; 26(6):779-89. PubMed ID: 6096607
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibitor of angiotensin I converting enzyme: (4R)-3-[(2S)-3-mercapto-2-methylpropanoyl]-4-thiazolidinecarboxylic acid (YS-980).
    Funae Y; Komori T; Sasaki D; Yamamoto K
    Biochem Pharmacol; 1980 Jun; 29(11):1543-7. PubMed ID: 6249321
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo comparison of three orally active inhibitors of angiotensin-converting enzyme.
    DiNicolantonio R; Dinicolantonio R; Hutchinson JS; Mendelsohn FA; Doyle AE
    Am J Cardiol; 1982 Apr; 49(6):1502-4. PubMed ID: 6280478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the acute effects of three structurally different converting enzyme inhibitors (captopril, SA-446 and MK-421) on blood pressure, the renin-angiotensin system and the kallikrein-kinin system.
    Kondo K; Kida O; Kodama K; Higa T; Someya N; Morotomi Y; Tanaka K
    Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):337-42. PubMed ID: 2991635
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of converting enzyme inhibitors on renin-angiotensin system in normal rats.
    Komori T; Takada T; Funae Y; Yamamoto K
    Osaka City Med J; 1984 Jun; 30(1):17-30. PubMed ID: 6096787
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of angiotensin converting enzyme inhibitor (SA-446) on regional hemodynamics in renal and spontaneously hypertensive rats.
    Abe Y; Sakamoto W; Fukui K; Iwao H; Takada T; Yamamoto K
    Arch Int Pharmacodyn Ther; 1988; 292():237-47. PubMed ID: 3395170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal excretion of an angiotensin I converting enzyme inhibitor (SA-446) in dogs.
    Abe Y; Okahara T; Miura K; Yukimura T; Takada T; Iwatani T; Iso T; Yamamoto K
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Apr; 325(4):356-9. PubMed ID: 6328337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of angiotensin-converting enzyme inhibitors on the vascular response to norepinephrine.
    Saruta T; Suzuki H; Okuno T; Kondo K
    Am J Cardiol; 1982 Apr; 49(6):1535-6. PubMed ID: 6176110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive effects of the novel converting-enzyme inhibitor YS 980 in spontaneously hypertensive rats.
    Unger T; Rockhold RW; Bönner G; Rascher W; Schaz K; Speck G; Schömig A; Ganten D
    Clin Exp Hypertens (1978); 1981; 3(1):121-40. PubMed ID: 6258887
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of inhibition of angiotensin I conversion by three converting enzyme inhibitors in rats.
    Takata Y; Di Nicolantonio R; Hutchinson JS
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():129-34. PubMed ID: 6183035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiative effects of a kinase II inhibitor (Ys980) on carrageenan-induced oedema in rat hind paw and roles of plasma kininogen.
    Suda H; Yamauchi H; Iso T
    J Pharm Pharmacol; 1982 Jan; 34(1):60-1. PubMed ID: 6121038
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of sodium loading on antihypertensive responses to an angiotensin-converting enzyme inhibitor in spontaneously hypertensive and renal hypertensive rats.
    Nakata K; Takada T; Yamauchi H; Iso T
    Eur J Pharmacol; 1986 Feb; 121(2):293-5. PubMed ID: 3009208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of three different kininase II inhibitors on blood pressure and renal vasoactive substances in essential hypertensives.
    Abe K; Tajima J; Omata K; Tanno M; Tsunoda K; Kudo K; Onoda Y; Kohzuki M; Sasaki S; Takeuchi K
    Adv Exp Med Biol; 1986; 198 Pt B():269-77. PubMed ID: 3028076
    [No Abstract]   [Full Text] [Related]  

  • 19. General pharmacological properties of the potent angiotensin converting enzyme inhibitor rentiapril.
    Yamauchi H; Nishimura K; Nakata K; Suda H; Iso T; Shimizu M; Hiramatsu Y
    Arzneimittelforschung; 1987 Feb; 37(2):157-64. PubMed ID: 3034298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of angiotensin-converting enzyme inhibitor YS980 on prostaglandin synthesis in rabbit kidney medulla slices.
    Fujimoto Y; Wada K; Kaneko M; Fujita T
    Br J Pharmacol; 1987 Nov; 92(3):479-81. PubMed ID: 3480765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.